Accelerate and De-risk Pre-clinical Research
Pre-clinical studies are about testing a new drug candidate in measurable ways to assess feasibility and safety. These studies are necessary precursors to studies in man. There are also scientific guidelines from the FDA and European Medicines Agency's on the non-clinical testing of medicines to help applicants prepare marketing authorisation applications. The selection of drug delivery systems within pre-clinical studies, however, is not well described.
This webinar will discuss the role of the drug delivery system in pre-clinical pulmonary and nasal drug development. We will highlight existing delivery strategies across animal species and perspectives on bridging device platforms.
Join this webinar to discover more about these scientific guidelines and how Aptar Pharma’s innovative devices for non-clinical research can meet unmet pharmaceutical needs and advance your molecule from formulation to patient. One new solution, PADA (Powder Administration Device for Animals), helps early phase pulmonary research, by enabling precise, rapid and efficient administration of a powder directly to the lungs of mice.
Key Learning Objective
- Understand the role of drug delivery systems in pre-clinical research
- Explore bridging device platforms
- Review Aptar Pharma’s device portfolio for early phase research and pre-clinical trials
Target Audience
- Heads of research and development
- University Research Departments
- Veterinary Researchers
- New Product Development
- Hospital Clinical Researchers
- Scientific Collaborators
- Scientists
- Senior Scientists
